New federal drug pricing regulations mean disaster for Canadians with rare diseases
New regs unfairly and unnecessarily target rare disease drugs and all new medicines – including life-saving cancer and curative gene therapies Proposed national pharmacare – including the Drugs for Rare Diseases Program – will be […]